The New Jersey Board of Pharmacy temporarily suspended the license of Christina Bekhit, owner of AllCare Pharmacy, after her arrest for selling falsified COVID-19 vaccination cards and entering false information into the state's immunization database. Under a consent order filed on July 5, 2022, Bekhit agreed to cease pharmacy operations and surrender her permit, addressing grave public health risks from fraudulent vaccination records.
Bekhit must immediately cease and desist from all pharmacy practice, discontinue or sell AllCare Pharmacy, and surrender her permit to operate, prohibiting her from engaging in pharmacy-related activities.
In-house legal teams should review all agreements where the entity handles sensitive health data or public health reporting, including vendor contracts with healthcare suppliers, customer/patient service agreements, and employee confidentiality/ethics agreements. Specific clauses to scrutinize are data accuracy and verification representations, compliance with state immunization registry reporting requirements, audit rights for health recordkeeping, termination provisions for illegal conduct or regulatory action, and indemnification clauses covering fines or sanctions. Given the falsification of state-managed vaccination records, contracts may need amendments to mandate real-time reporting validation, require immediate notification of any regulatory investigation, and impose stricter penalties for data manipulation. For pharmacy-specific agreements, ensure clauses align with state pharmacy board regulations on controlled substances and vaccination documentation.
Entity
AllCare Pharmacy
Also known as: AllCare
Industry
HealthcareOfficial Press Release
https://www.njoag.gov/nj-pharmacy-board-temporarily-suspends-license-of-hudson-county-pharmacist-arrested-for-allegedly-selling-fake-covid-19-vaccination-cards/
Bekhit Order Filed
https://www.nj.gov/oag/newsreleases22/Bekhit-Order-Filed.pdf
New Jersey Attorney General Enforcement Page
https://www.njoag.gov/about/divisions-and-offices/division-of-consumer-affairs/
"AllCare Pharmacy"
"entered false vaccination information into the New Jersey Immunization Information System database"
The New Jersey Attorney General announced the arrest of Christina Bekhit, a pharmacist operating AllCare Pharmacy, for selling fake COVID-19 vaccination record cards and entering false information into the state's immunization database. She faces criminal charges for computer criminal activity, tampering with public information, and falsification of medical records.
$18.0M
Attorney General Jennifer Davenport joined a bipartisan coalition of 42 attorneys general in announcing a settlement with the bankruptcy trustee for 23andMe, resolving allegations from a 2023 data breach that compromised genetic data of 6.9 million people worldwide, including nearly 150,000 in New Jersey. The settlement provides $18 million to states from available bankruptcy funds, plus enhanced data security and consumer deletion rights for the successor entity, 23andMe Research Institute.
$45.0M
Block, Inc. agreed to a $45 million multistate settlement with 46 states for allegedly misleading consumers about the safety of Cash App, failing to protect users from fraud, and not providing promised fraud protection. The settlement requires Block to improve customer support, stop misleading claims, and educate consumers about fraud.
Attorney General Jennifer Davenport co-led a coalition of 49 attorneys general in calling on the FCC to strengthen rules to cut off scammers' access to legitimate telephone numbers. The coalition's letter requests stronger certification rules, regular reporting, and prohibitions on number cycling to combat illegal robocalls.
Governor Sherrill and Attorney General Davenport announced coordinated executive actions to reduce and eliminate junk fees in New Jersey. The initiative includes an Executive Order directing state agencies to review industries for junk fees and an Enforcement Statement from the Division of Consumer Affairs explaining how junk fee practices may violate the New Jersey Consumer Fraud Act.
The New Jersey Bureau of Securities announced its 2026 annual investment adviser examination, with a particular focus on firms' use of artificial intelligence and cybersecurity protocols. The examination requires nearly 800 registered investment adviser firms to answer questions about AI use in portfolio management, data protection policies, and third-party vendor due diligence. Failure to comply may result in administrative action.